The wide spectrum of steatohepatitis: A report of four cases and a review of the literature

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 10, 2004, Pages 1043-1050

  Lonardo, Amedeo ^a,b   Bagni, Alberto ^a   Tarugi, Patrizia ^a   Loria, Paola ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Ospedale Civile   (Italy)

Author keywords

Alcohol; Diabetes; Familial heterozygous hypobetalipoproteinaemia; Ferritin; Hepatitis C; Hepatocellular carcinoma; Lipodystrophy; Non alcoholic fatty liver disease; Obesity; Uric acid

Indexed keywords

FERRITIN; URIC ACID DERIVATIVE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ALCOHOLISM; BODY MASS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE SEVERITY; DYSLIPIDEMIA; ECHOGRAPHY; EDEMA; FAMILIAL DISEASE; FAMILY HISTORY; FATTY LIVER; FEMALE; FERRITIN BLOOD LEVEL; HEPATITIS; HEPATITIS C; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPOBETALIPOPROTEINEMIA; LIPODYSTROPHY; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER HEMANGIOMA; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOM; URIC ACID BLOOD LEVEL;

ADULT; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS C; HUMANS; LIVER; MALE; MIDDLE AGED; OBESITY; RISK FACTORS;

EID: 6944227685     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200410000-00015     Document Type: Review

References (71)

1. Brunt EM, Tiniakos DG. Pathology of steatohepatitis. Best Pract Res Clin Gastroenterol 2002; 16:691-707.
2. Brunt EM. Alcoholic and non-alcoholic steatohepatitis. Clin Liver Dis 2002; 6:399-420.
3. Diehl AM, Goodman Z, Ishak KG. Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988; 95:1056-1062.
4. Cortez-Pinto H, Baptista A, Camilo ME, Valente A, Saragoca A, de Moura MC. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci 1996; 41:172-179.
5. Lonardo A, Loria P. Of liver, whisky and plants: a requiem for colchicine in alcoholic cirrhosis? Eur J Gastroenterol Hepatol 2002; 14:355-358.
6. Day CP, Saksena S. Non-alcoholic steatohepatitis: definitions and pathogenesis. J Gastroenterol Hepatol 2002; 17:S377-S384.
7. Vryheid RE, Yu ES, Mehta KM, McGhee J. The declining prevalence of hepatitis B virus infection among Asian and Pacific Islander children. Asian Am Pac Isl J Health 2001; 9:162-178.
8. Gaeta GB, Stornaiuolo G, Precone DF. Type B and D viral hepatitis: epidemiological changes in Southern Europe. Forum 2001; 11: 126-133.
9. Saracco G, Olivero A, Ciancio A, Carenzi S, Rizzetto M. Therapy of chronic hepatitis C: a critical review. Curr Drug Targets Infect Disord 2003; 3:25-32.
10. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346:1221-1231.
11. Sanyal AJ. American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 123:1705-1725.
12. Brunt EM, Rarakhiani S, Cordes BG, Neuschwander-Tetri BA, Janney CG, Bacon BR, Di Bisceglie AM. Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease. Mod Pathol 2003; 16:49-56.
13. Clouston AD, Powell EE. Interaction of non-alcoholic fatty liver disease with other liver diseases. Best Pract Res Clin Gastroenterol 2002; 16:767-781.
14. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94:2467-2474.
15. Powell E, Cooksley W, Hanson R, Searle J, Halliday J, Powell L. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11:74-80.
16. Abdelmalek M, Ludwig J, Lindor KD. Two cases from the spectrum of nonalcoholic steatohepatitis. J Clin Gastroenterol 1995; 20:127-130.
17. Monto A. Hepatitis C and steatosis. Semin Gastrointest Dis 2002; 13:40-46.
18. Lonardo A, Adinolfi L, Loria P, Carulli N, Ruggiero L, Day CP. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology 2004; 126:586-597.
19. Hickman IJ, Clouston AD, Macdonald GA, Purdie DM, Prins JB, Ash S, et al. Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut 2002; 51:89-94.
20. Lonardo A. Fatty liver and nonalcoholic steatohepatitis. Where do we stand and where are we going? Dig Dis 1999; 17:80-89.
21. Youssef W, McCullough AJ. Diabetes mellitus, obesity and hepatic steatosis. Sem Gastrointest Dis 2002; 13:17-30.
22. Younossi ZM, Matteoni CA. Diabetes and non-alcoholic fatty liver disease: a worrisome combination [Abstract]. Gastroenterology 1999; 116:1292.
23. Romero-Gomez M, Castellano-Megias VM, Grande L, Irles JA, Criz M, Nogales MC, et al. Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C. Am J Gastroenterol 2003; 98:1135-1141.
24. Powell EE, Searle J, Mortimer R. Steatohepatitis associated with limb lipodystrophy. Gastroenterology 1989; 97:1022-1024.
25. Misra A, Garg A. Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature. Medicine 2003; 82:129-146.
26. Garg A, Misra A. Hepatic steatosis, insulin resistance, and adipose tissue disorders. J Clin Endocrinol Metab 2002; 87:3019-3022.
27. Caldwell SH, Oelsener DH, lezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999; 29:664-669.
28. Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000; 32:689-692.
29. Ayata G, Gordon FD, Lewis WD, Pomfret E, Pomposelli JJ, Jenkins RL, Khettry U. Cryptogenic cirhosis: clinicopathologic findings at and after liver transplantation. Hum Pathol 2002; 33:1098-1104.
30. Amarapurkar D, Das HS. Chronic liver disease in diabetes mellitus. Trop Gastroenterol 2002; 23:3-5.
31. Contos MJ, Cales W, Sterling RK, Luketic VA, Shiffman ML, Mills AS, et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl 2001; 7:363-373.
32. Ong J, Younossi ZM, Reddy V, Price LL, Gramlich T, Mayes J, Boparai N. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease. Liver Transpl 2001; 7:797-801.
33. Struben VM, Hespenheide EE, Caldwell SH. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am J Med 2000; 108:9-13.
34. Ludwig J, McGill DB, Lindor KB. Review: nonalcoholic steatohepatitis. J Clin Gastroenterol 1995; 20:127-130.
35. Cotrim HP, Parana R, Braga E, Lyra L. Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history? Am J Gastroenterol 2000; 95:3018-3019.
36. Orikasa H, Ohyama R, Tsuka N, Eyden BP, Yamazaki K. Lipid-rich clear-cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis in a patient with diabetes mellitus. J Submicroscop Cytol Pathol 2001; 33:195-200.
37. Zen Y, Katayanagi K, Tsuneyama K, Harada K, Araki I, Nakanuma Y. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. Pathol Int 2001; 51:127-131.
38. Shimada M, Hashimoto E, Taniani M, Hasegawa K, Okuda H, Hayashi N, et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 2002; 37:154-160.
39. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002; 123:134-140.
40. Yang S, Lin HZ, Hwang J, Chacko VP, Diehl AM. Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res 2001; 61:5016-5023.
41. Balkau B, Eschwège E, Kahn HS, Ducimitière P, Courbon D. Hyperinsulinemia predicts fatal liver cancer but is inversely associated with fatal cancer at some other sites. Diabetes Care 2001; 24:843-849.
42. Linton MR, Farese RV, Young SG. Familial hypobetalipoproteinemia. J Lipid Res 1993; 34:521-541.
43. Kane GP, Havel EJ. Disorders of the biogenesis and secretion of lipoproteins containing the B lipoproteins. In: Scriver CR, Beaudet AL, Sly S, Valle D (editors): The Metabolic and Molecular Basis of Inherited Disease, vol. 2, 7th edition. New York: McGrawHill; 1995; pp. 1853-1885.
44. Hagve TA, Myrseth E, Schrumpf JP, Blomhoff P, Chrisphersen K, Elgjo K, et al. Liver steatosis in hypobetalipoproteinemia. J Hepatol 1991; 13:104-111.
45. Wishingrad M, Paaso B, Garcia G. Fatty liver due to heterozygous hypobetalipoproteinemia. Am J Gastroenterol 1994; 89:1106-1107.
46. Castellano G, Garfia C, Gomez-Coronado D, Arenas J, Manzanares J, Colina F, Solis-Herruzo A. Diffuse fatty liver in familial hypobetalipoproteinemia. J Clin Gastroenterol 1997; 25:379-382.
47. Ogata H, Akagi K, Baba M, Nagamatsu A, Suzuki N, Nomiyama K, Fujishima M. Fatty liver in a case with heterozygous familial hypobetalipoproteinemia. Am J Gastroenterol 1997; 92:339-342.
48. Mehta NN, Desai HG. Persistent transaminase elevation due to heterozygous (familial) apolipoprotein deficiency. Indian J Gastroenterol 1997; 16:158-159.
49. Ahmed A, Keefe EB. Asymptomatic elevation of aminotransferase levels and fatty liver secondary to heterozygous hypobetalipoproteinemia. Am J Gastroenterol 1998; 93:2598-2599.
50. Tarugi P, Lonardo A, Ballarini G, Grisendi A, Pulvirenti M, Bagni A, Calandra G. Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B. Gastroenterology 1996; 111:1125-1133.
51. Tarugi P, Lonardo A, Ballarini G, Erspamer L, Tondelli E, Bertolini S, Calandra S. A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (ApoB-54.5). J Hepatol 2000; 33:361-370.
52. Tarugi P, Lonardo A, Gabelli C, Sala G, Cortella I, Previato L, et al. Phenotypic expression of familial hypobetalipoproteinemia in three kindreds with mutations of apolipoprotein B gene. J Lipid Res 2001; 42:1552-1561.
53. Schonfeld G, Patterson BW, Yablonskiy DA, Tanoli TSK, Avema M, Yue P, Ackerman J. Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis. J Lipid Res 2003; 44:470-478.
54. Lonardo A, Tarugi P, Ballarini G, Bagni A. Familial heterozygous hypobetalipoproteinemia, extrahepatic primary malignancy, and hepatocellular carcinoma. Dig Dis Sci 1998; 43:2489-2492.
55. Scheen AJ, Luyckx FH. Obesity and liver disease. Best Pract Res Clin Endocrinol Metab 2002; 16:703-716.
56. O'Brien PE, Dixon JB. The extent of the problem of obesity. Am J Surg 2002; 184:4S-8S.
57. Andersen T, Gluud C. Liver morphology in morbid obesity: a literature study. Int J Obes 1984; 8:97-106.
58. Day CP, James OF. Steatohepatitis: a tale of two hits? Gastroenterology 1998; 114:842-845.
59. Day CP, James OF. Hepatic steatosis: innocent bystander or guilty party? Hepatology 1998; 27:1463-1466.
60. Parola M, Leonarduzzi G, Robino G, Albano E, Poli G, Dianzani MU. On the role of lipid peroxidation in the pathogenesis of liver damage induced by long-standing cholestasis. Free Radic Biol Med 1996; 20:351-359.
61. Bedossa P, Houglum K, Trautwein C, Holstege A, Chojkier M. Stimulation of collagen alpha 1 (I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis? Hepatology 1994; 19:1262-1271.
62. Pessayre D, Berson A, Fromenty B, Mansouri A. Mitochondria in steatohepatitis. Semin Liver Dis 2001; 21:57-69.
63. Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995; 22: 1714-1719.
64. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. Hepatology 1997; 25: 108-111.
65. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, Kral JG. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999; 84:1513-1517.
66. Ratziu V, Bonyhay L, Di Martino V, Charlotte F, Cavallaro L, Sayegh-Tainturier MH, et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002; 35:1485-1493.
67. Nair S, Cope K, Terence RH, Diehl AM. Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of non-alcoholic steatohepatitis. Am J Gastroenterol 2001; 96:1200-1204.
68. Iturriaga H, Bunuot D, Hirsch S, Ugarte G. Overweight as a risk factor or a predictive sign of histological liver damage in alcoholics. Am J Clin Nutr 1988; 47:235-238.
69. Raynard B, Balian A, Fallik D, Capron F, Bedossa P, Chaput JC, Naveau S. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 2002; 35:635-638.
70. Greco M, De Micheli E, Lonardo A. Multifactorial liver disease following biliopancreatic diversion. Report of a case. Ann Ital Med Int 2003; 18:99-103.
71. Facchini FS, Hua NW, Stoohs RA. Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. Gastroenterology 2002; 122:931-939.